291
TITLE: Is seronegative TSP a possible HTLV-I/II associated myelopathy?
AUTHORS: Costa, CMD; Santos, TJT; Haddad, SK; Takayanagui, O; Vandamme, AM; Goubau, P; Carton, H;
PUBLISHED: 2001, SOURCE: AIDS RESEARCH AND HUMAN RETROVIRUSES, VOLUME: 17
INDEXED IN: WOS
292
TITLE: Simple algorithm derived from a geno-/phenotypic database to predict HIV-1 protease inhibitor resistance
AUTHORS: Schmidt, B; Walter, H; Moschik, B; Paatz, C; van Vaerenbergh, K; Vandamme, AM; Schmitt, M; Harrer, T; Uberla, K; Korn, K;
PUBLISHED: 2000, SOURCE: 2nd Symposium on the Clinical Implications on HIV Drug Resistance in AIDS, VOLUME: 14, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef
293
TITLE: Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
AUTHORS: Van Vaerenbergh, K; Van Laethem, K; Albert, J; Boucher, CAB; Clotet, B; Floridia, M; Gerstoft, J; Hejdeman, B; Nielsen, C; Pannecouque, C; Perrin, L; Pirillo, MF; Ruiz, L; Schmit, JC; Schneider, F; Schoolmeester, A; Schuurman, R; Stellbrink, HJ; Stuyver, L; Van Lunzen, J; Van Remoortel, B; Van Wijngaerden, E; Vella, S; Witvrouw, M; Yerly, S; De Clercq, E; Desmyter, J; Vandamme, AM; ...More
PUBLISHED: 2000, SOURCE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 44, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef
294
TITLE: Second Spanish Consensus on the Use of Drug Resistance Testing in Clinical Practice (Madrid, March 2000)
AUTHORS: Soriano, V; Ledesma, E; Aguilera, A; Antela, A; Arribas, J; Barreiro, P; Blanco, F; Briones, C; Clotet, B; Dalmau, D; Gatell, JM; Gonzales Lahoz, J; Leal, M; Martinez Picado, X; De Mendoza, C; Miro, JM; Moreno, S; Pedreina, J; Podzamczer, D; Pumarola, T; Rodriguez, C; Rodriguez Rosado, R; Del Romero, J; Rubio, R; Ruiz, L; Havlir, D; Vandamme, AM; Wainberg, M; Youle, M; ...More
PUBLISHED: 2000, SOURCE: AIDS Reviews, VOLUME: 2, ISSUE: 2
INDEXED IN: Scopus
IN MY: ORCID
295
TITLE: A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: Inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry
AUTHORS: Daelemans, D; Schols, D; Witvrouw, M; Pannecouque, C; Hatse, S; van Dooren, S; Hamy, F; Klimkait, T; De Clercq, E; Vandamme, AM;
PUBLISHED: 2000, SOURCE: MOLECULAR PHARMACOLOGY, VOLUME: 57, ISSUE: 1
INDEXED IN: Scopus WOS
296
TITLE: Evolving viruses and virologists  Full Text
AUTHORS: Vandamme, AM;
PUBLISHED: 2000, SOURCE: Trends in Microbiology, VOLUME: 8, ISSUE: 1
INDEXED IN: Scopus CrossRef
IN MY: ORCID
297
TITLE: Tempo and mode of human and simian T-lymphotropic Virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences
AUTHORS: Salemi, M; Desmyter, J; Vandamme, AM;
PUBLISHED: 2000, SOURCE: MOLECULAR BIOLOGY AND EVOLUTION, VOLUME: 17, ISSUE: 3
INDEXED IN: Scopus WOS
298
TITLE: Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: Studies of infected donor-recipient clusters
AUTHORS: Allain, JP; Dong, Y; Vandamme, AM; Moulton, V; Salemi, M;
PUBLISHED: 2000, SOURCE: JOURNAL OF VIROLOGY, VOLUME: 74, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
299
TITLE: Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir
AUTHORS: Van Laethem, K; Witvrouw, M; Balzarini, J; Schmit, JC; Sprecher, S; Hermans, P; Leal, M; Harrer, T; Ruiz, L; Clotet, B; Van Ranst, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
300
TITLE: Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories  Full Text
AUTHORS: Muyldermans, G; Debaisieux, L; Fransen, K; Marissens, D; Miller, K; Vaira, D; Vandamme, AM; Vandenbroucke, AT; Verhofstede, C; Schuurman, R; Zissis, G; Lauwers, S;
PUBLISHED: 2000, SOURCE: CLINICAL MICROBIOLOGY AND INFECTION, VOLUME: 6, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
Page 30 of 42. Total results: 418.